Survival and prognostic factors in node-negative breast cancer: results of long-term follow-up studies.
Seven hundred sixty-seven patients treated at the Memorial Sloan-Kettering Cancer Center from 1964 through 1970 by mastectomy and axillary dissection have now been followed for a median of 18 years. This unusual database consists of a consecutive series of women cared for by physicians specialized in the treatment of breast cancer in one institution. The data suggest that patients with T1, N0, M0 tumors of 1 cm or less may be "cured" by mastectomy and axillary dissection, the estimated proportion of "cured" patients being 89%. The data also suggest that node-negative patients can be placed in categories of risk for recurrence on the basis of primary tumor size.
Rosen
P P
PP
Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021.
Groshen
S
S
Kinne
D W
DW
D001943:Breast Neoplasms / Q000401:mortality* / Q000473:pathology / Q000628:therapy; D003131:Combined Modality Therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008207:Lymphatic Metastasis; D009361:Neoplasm Invasiveness; D009362:Neoplasm Metastasis; D016609:Neoplasms, Second Primary; D011379:Prognosis; D012307:Risk Factors; D015996:Survival Rate; D013997:Time Factors